← Back to Patent Explorer
US5654178A Expired / Lapsed US ⏱️ 0.0 years remaining

Immunoassay for tetrachloroisophthalonitrile (chlorothalonil), its derivatives and breakdown products

Assignee: GB Biosciences Corp
•
Filing: 1995-06-07
•
Granted: 1997-08-05
•
Expires: 2015-06-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel derivatives of chlorothalanil TM (tetrachloroisophthalonitrile, TCPN), permit conjugation of the TCPN derivative to a carrier useful as an immunogen to induce antibodies specific for TCPN or a TCPN metabolite, or a screening antigen to detect such antibodies. Polyclonal and monoclonal antibodies specific for TCPN or a TCPN metabolite, as well as hybridoma cells producing such antibodies are disclosed. Also provided are immunoassay methods for detection and quantitation of pesticide chemicals, in particular, the fungicide TCPN or a TCPN metabolite, and kits containing a TCPN derivative screening antigen, an anti-TCPN or anti-TCPN metabolite antibody useful for performing the immunoassays.

Inventors

  • 👤 Donna A. Fitzpatrick
  • 👤 Bharat B. Kikani
  • 👤 Frank P. Petersen
  • 👤 James H. Rittenburg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 20:03
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/44; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/5308

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 40 words
An antibody useful in an immunoassay to detect or measure tetrachloroisophthalonitrile (TCPN) or a TCPN metabolite in a sample, wherein i) said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile, or 3-carbamyl-2,4,5-trichlorobenzoic acid; and ii) said antibody specifically binds TCPN or said TCPN metabolite.
Claim 2
Dependent Claim 40 words
An antibody useful in an immunoassay to detect or measure tetrachloroisophthalonitrile (TCPN) or a TCPN metabolite in a sample, wherein i) said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile, or 3-carbamyl-2,4,5-trichlorobenzoic acid; and ii) said antibody specifically binds TCPN or said TCPN metabolite.
Claim 3
Dependent Claim 13 words
The antibody of claim 1, which specifically binds tetrachloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, and 3-carbamyl-2,4,5-trichlorobenzoic acid.
Claim 4
Dependent Claim 28 words
The antibody of claim 1, which is a polyclonal antibody, and which specifically binds tetrachloroisophthalonitrile and exhibits no greater than about 0.5% cross-reactivity with 4-hydroxy-2,5,6-trichloroisophthalonitrile in said immunoassay.
Claim 5
Dependent Claim 28 words
The antibody of claim 1, which is a polyclonal antibody, and which specifically binds tetrachloroisophthalonitrile, and exhibits less than about 0.01% cross-reactivity with 3-carbamyl-2,4,5-trichlorobenzoic acid in said immunoassay.
Claim 6
Dependent Claim 9 words
The antibody of claim 1, which specifically binds tetrachloroisophthalonitrile.
Claim 7
Dependent Claim 28 words
The antibody of claim 1, which is a polyclonal antibody and is capable of detecting tetrachloroisophthalonitrile at about 5.0 parts per billion of said sample in said immunoassay.
Claim 8
Dependent Claim 9 words
The antibody of claim 1, which specifically binds 4-hydroxy-2,5,6-trichloroisophthalonitrile.
Claim 9
Dependent Claim 10 words
The antibody of claim 1, which specifically binds 3-carbamyl-2,4,5-trichlorobenzoic acid.
Claim 10
Dependent Claim 16 words
A monoclonal antibody produced by the 6F9 hybridoma cell line having ATCC accession number HB 11395.
Claim 11
Dependent Claim 16 words
A monoclonal antibody produced by the 6F9 hybridoma cell line having ATCC accession number HB 11395.
Claim 12
Dependent Claim 10 words
Hybridoma cell line 6F9 having ATCC accession number HB 11395.
Claim 13
Dependent Claim 10 words
Hybridoma cell line 6F9 having ATCC accession number HB 11395.
Claim 14
Dependent Claim 44 words
An antibody useful in an immunoassay to detect or measure a TCPN derivative in a sample, wherein i) said TCPN derivative is a compound selected from the group consisting of 4-amino-2,5,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 5-hydroxy-2,4,6-trichloroisophthalonitrile, and 5-amino-2,4,6-trichloroisophthalonitrile; and ii) said antibody specifically binds the TCPN derivative.
Claim 15
Dependent Claim 44 words
An antibody useful in an immunoassay to detect or measure a TCPN derivative in a sample, wherein i) said TCPN derivative is a compound selected from the group consisting of 4-amino-2,5,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 5-hydroxy-2,4,6-trichloroisophthalonitrile, and 5-amino-2,4,6-trichloroisophthalonitrile; and ii) said antibody specifically binds the TCPN derivative.
Claim 16
Dependent Claim 13 words
The antibody of claim 11, which specifically binds 4-amino-2,5,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 5-hydroxy-2,4,6-trichloroisophthalonitrile, and 5-amino-2,4,6-trichloroisophthalonitrile.
Claim 17
Dependent Claim 35 words
An antibody according to any of claims 1-12 produced by immunizing an animal with a protein carrier conjugated with a compound selected from the group consisting of 5-hydroxy-2,4,6-trichloroisophthalonitrile, 5-amino-2,4,6-trichloroisophthalonitrile, 5-mercapto-2,4,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, tetrachloroisophthalonitrile, 3-carbamyl-2,4,5-trichlorobenzoic acid.
Claim 18
Dependent Claim 17 words
The antibody of claim 13, wherein said carrier protein is bovine serum albumin or keyhole limpet hemocyanin.
Claim 19
Dependent Claim 101 words
A method for isolating from a complex mixture a compound capable of binding to the antibody of claim 1 or 2, wherein said compound is (i) 4-hydroxy-2,5,6-trichloroisophthalonitrile, or 3-carbamyl-2,4,5-trichlorobenzoic acid, or (ii) a protein conjugated with a chemical selected from the group consisting of 5-hydroxy-2,4,6-trichloroisophthalonitrile, 5-amino-2,4,6-trichloroisophthalonitrile, 5-mercapto-2,4,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, tetrachloroisophthalonitrile, and 3-carbamyl-2,4,5-trichlorobenzoic acid, and said method comprises: (a) immobilizing said antibody on a solid phase support or carrier; (b) contacting said complex mixture with said immobilized antibody allowing said compound to bind to said antibody, and washing away any unbound material; and (c) eluting said bound compound, thereby isolating said compound.
Claim 20
Independent Claim 151 words
A method for producing a hybridoma cell line that produces a monoclonal antibody that specifically binds tetrachloroisophthalonitrile (TCPN) or a TCPN metabolite, wherein said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile, or 3-carbamyl-2,4,5-trichlorobenzoic acid, and said method comprises: (a) immunizing a donor animal with a protein carrier conjugated with a compound selected from the group consisting of 5-hydroxy-2,4,6-trichloroisophthalonitrile, 5-amino-2,4,6-trichloroisophthalonitrile, 5-mercapto-2,4,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, tetrachloroisophthalonitrile, and 3-carbamyl-2,4,5-trichlorobenzoic acid; (b) obtaining B lymphocytes from said immunized donor animal; (c) fusing said B lymphocytes with cells of a fusion partner cell line to obtain hybrid cells; and (d) selecting hybrid cells which produce antibodies that specifically binds TCPN or a TCPN metabolite by: (i) culturing said hybrid cells; (ii) screening the medium of said cultures for the presence of an antibody which binds to TCPN or a TCPN metabolite; thereby detecting antibody producing hybrid cells; and (e) growing said selected hybrid cells, thereby producing said hybridoma cell line.
Claim 21
Independent Claim 151 words
A method for producing a hybridoma cell line that produces a monoclonal antibody that specifically binds tetrachloroisophthalonitrile (TCPN) or a TCPN metabolite, wherein said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile, or 3-carbamyl-2,4,5-trichlorobenzoic acid, and said method comprises: (a) immunizing a donor animal with a protein carrier conjugated with a compound selected from the group consisting of 5-hydroxy-2,4,6-trichloroisophthalonitrile, 5-amino-2,4,6-trichloroisophthalonitrile, 5-mercapto-2,4,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, tetrachloroisophthalonitrile, and 3-carbamyl-2,4,5-trichlorobenzoic acid; (b) obtaining B lymphocytes from said immunized donor animal; (c) fusing said B lymphocytes with cells of a fusion partner cell line to obtain hybrid cells; and (d) selecting hybrid cells which produce antibodies that specifically binds TCPN or a TCPN metabolite by: (i) culturing said hybrid cells; (ii) screening the medium of said cultures for the presence of an antibody which binds to TCPN or a TCPN metabolite; thereby detecting antibody producing hybrid cells; and (e) growing said selected hybrid cells, thereby producing said hybridoma cell line.
Claim 22
Dependent Claim 60 words
A method for producing a monoclonal antibody that specifically binds tetrachloroisophthalonitrile (TCPN) or a TCPN metabolite, wherein said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile, or 3-carbamyl-2,4,5-trichlorobenzoic acid, and which method comprises: (a) culturing a hybridoma cell line according to claim 10 under conditions which permit antibody production and secretion by said cell line; and (b) obtaining the culture medium containing said antibody.
Claim 23
Independent Claim 97 words
A method for producing an antibody that specifically binds tetrachloroisophthalonitrile (TCPN), a TCPN metabolite or a TCPN derivative, which comprises i) immunizing an animal with a macromolecular carrier conjugated with a compound selected from the group consisting of 5-hydroxy-2,4,6-trichloroisophthalonitrile, 5-amino-2,4,6-trichloroisophthalonitrile, 5-mercapto-2,4,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, tetrachloroisophthalonitrile, and 3-carbamyl-2,4,5-trichlorobenzoic acid; and ii) screening the serum of the animal for an antibody that specifically binds tetrachloroisophthalonitrile (TCPN), a TCPN metabolite or a TCPN derivative; wherein said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile or 3-carbamyl-2,4,5-trichlorobenzoic acid, and said TCPN derivative is a compound selected from the group consisting of 4-amino-2,5,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 5-hydroxy-2,4,6-trichloroisophthalonitrile, and 5-amino-2,4,6-trichloroisophthalonitrile.
Claim 24
Independent Claim 97 words
A method for producing an antibody that specifically binds tetrachloroisophthalonitrile (TCPN), a TCPN metabolite or a TCPN derivative, which comprises i) immunizing an animal with a macromolecular carrier conjugated with a compound selected from the group consisting of 5-hydroxy-2,4,6-trichloroisophthalonitrile, 5-amino-2,4,6-trichloroisophthalonitrile, 5-mercapto-2,4,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 4-hydroxy-2,5,6-trichloroisophthalonitrile, tetrachloroisophthalonitrile, and 3-carbamyl-2,4,5-trichlorobenzoic acid; and ii) screening the serum of the animal for an antibody that specifically binds tetrachloroisophthalonitrile (TCPN), a TCPN metabolite or a TCPN derivative; wherein said TCPN metabolite is 4-hydroxy-2,5,6-trichloroisophthalonitrile or 3-carbamyl-2,4,5-trichlorobenzoic acid, and said TCPN derivative is a compound selected from the group consisting of 4-amino-2,5,6-trichloroisophthalonitrile, 4-mercapto-2,5,6-trichloroisophthalonitrile, 5-hydroxy-2,4,6-trichloroisophthalonitrile, and 5-amino-2,4,6-trichloroisophthalonitrile.
Claim 25
Dependent Claim 13 words
The method according to claim 18, wherein the macromolecular carrier is a protein.

References Cited (Backward Citations)

US4822902A Cited
US4530786A Cited
EP0340198A1 Cited
EP0365818A1 Cited
US5064845A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-08-04 2001-02-03 2001-08-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-08-04 2005-02-03 2005-08-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-08-04 2009-02-03 2009-08-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag